Chapman Financial Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.1K Sell
361
-1,332
-79% -$126K 0.02% 197
2026
Q2
$146K Sell
1,693
-391
-19% -$34.3K 0.1% 140
2026
Q1
$188K Sell
2,084
-520
-20% -$47.7K 0.13% 134
2025
Q4
$234K Hold
2,604
– – 0.16% 120
2025
Q3
$256K Buy
2,604
+215
+9% +$21.3K 0.18% 113
2025
Q2
$218K Buy
+2,389
New +$231K 0.18% 95
2024
Q4
$1.17M Buy
+10,972
New +$1.18M 0.94% 34

Other funds holding ZBH

Chapman Financial Group's ZBH Position: Q3 2026 in Review

Chapman Financial Group reduced its Zimmer Biomet (ZBH) stake by 79% in Q3 2026, selling an estimated $126K and leaving 361 shares worth $32.1K. The position accounts for 0.02% of the portfolio, ranked #197.

Chapman Financial Group first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.17M in Q4 2024. 933 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Chapman Financial Group held 361 shares of Zimmer Biomet worth $32.1K as of Q3 2026.
  • Chapman Financial Group sold 1,332 Zimmer Biomet shares in Q3 2026, an estimated $126K.
  • Zimmer Biomet made up 0.02% of Chapman Financial Group's portfolio in Q3 2026, its #197 holding.
  • Chapman Financial Group first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • Chapman Financial Group's Zimmer Biomet position peaked at $1.17M in Q4 2024.
  • 933 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.